West Pharmaceutical Services (WST) Enterprise Value (2016 - 2025)
Historic Enterprise Value for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to -$628.5 million.
- West Pharmaceutical Services' Enterprise Value fell 2803.01% to -$628.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$628.5 million, marking a year-over-year decrease of 2803.01%. This contributed to the annual value of -$484.6 million for FY2024, which is 4324.86% up from last year.
- According to the latest figures from Q3 2025, West Pharmaceutical Services' Enterprise Value is -$628.5 million, which was down 2803.01% from -$509.7 million recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Enterprise Value ranged from a high of -$404.2 million in Q1 2025 and a low of -$898.6 million during Q3 2023
- In the last 5 years, West Pharmaceutical Services' Enterprise Value had a median value of -$667.7 million in 2022 and averaged -$659.0 million.
- Per our database at Business Quant, West Pharmaceutical Services' Enterprise Value crashed by 4425.89% in 2021 and then soared by 4537.06% in 2024.
- West Pharmaceutical Services' Enterprise Value (Quarter) stood at -$762.6 million in 2021, then dropped by 17.27% to -$894.3 million in 2022, then increased by 4.52% to -$853.9 million in 2023, then skyrocketed by 43.25% to -$484.6 million in 2024, then decreased by 29.69% to -$628.5 million in 2025.
- Its Enterprise Value was -$628.5 million in Q3 2025, compared to -$509.7 million in Q2 2025 and -$404.2 million in Q1 2025.